These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6441536)

  • 41. Centrally mediated hypotensive effect of E coli endotoxin in the anesthetized cat.
    Koyama S; Santiesteban HL; Ammons WS; Manning JW
    Circ Shock; 1982; 9(6):557-70. PubMed ID: 6758978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in man.
    Corsini GU; Del Zompo M; Piccardi MP; Mangoni A; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):123-30. PubMed ID: 756167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contribution of spinal dopamine receptors to the hypotensive action of bromocriptine in rats.
    Lahlou S; Demenge P
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):317-25. PubMed ID: 1720830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central mechanisms for apomorphine-induced emesis in the dog.
    Harding RK; Hugenholtz H; Kucharczyk J; Lemoine J
    Eur J Pharmacol; 1987 Nov; 144(1):61-5. PubMed ID: 3436361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
    Shropshire AT; Wendt RL
    J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.
    Goiny M; Uvnäs-Moberg K; Cekan S
    Psychopharmacology (Berl); 1986; 89(1):108-12. PubMed ID: 3090584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of adrenal medulla and neurohypophysis in the central and peripheral cardiovascular effects of neurohypophysial peptides.
    Montastruc JL; Dang Tran L
    Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):299-308. PubMed ID: 6486975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
    Mercuro G; Rossetti Z; Rivano AC; Tocco L; Ruscazio M; Stefanini E; Gessa GL; Cherchi A
    Cardiologia; 1987 Jul; 32(7):643-50. PubMed ID: 3690588
    [No Abstract]   [Full Text] [Related]  

  • 49. Antihypertensive action of bromocriptine in neurogenic hypertensive dogs.
    Montastruc JL; Montastruc P
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):210-8. PubMed ID: 7305559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of lysine-vasopressin and oxytocin on central cardiovascular control.
    Tran LD; Montastruc JL; Montastruc P
    Br J Pharmacol; 1982 Sep; 77(1):69-73. PubMed ID: 7126997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of dopaminergic drugs on plasma levels of steroid hormones in conscious dogs.
    Goiny M; Cekan S; Uvnäs-Moberg K
    Life Sci; 1986 Jun; 38(25):2293-300. PubMed ID: 3724358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A study of the action of clonidine on secretion from the adrenal medulla in dogs.
    Anglade F; Dang Tran L; De Saint Blanquat G; Gaillard G; Michel-Damase C; Montastruc JL; Montastruc P; Rostin M; Tran MA
    Br J Pharmacol; 1987 Jul; 91(3):481-6. PubMed ID: 3607366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of intrahippocampal administration of dopamine or apomorphine on EEG of limbic structures in the rabbit brain.
    Smialowski A
    Pol J Pharmacol Pharm; 1976; 28(6):579-85. PubMed ID: 1012981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antihypertensive effects of mesulergine: further evidence for a peripheral site of action of dopamine agonists.
    Begaud B; Dang Tran L; Montastruc JL; Montastruc P
    Fundam Clin Pharmacol; 1987; 1(3):153-9. PubMed ID: 3428838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of cholinergic mechanisms in the central cardiovascular actions of nicardipine in dogs.
    Montastruc JL; Dang Tran L; Huchet-Brisac AM; Chelly J; Rostin M; Montastruc P
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):212-6. PubMed ID: 3426347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral circulatory effects of a dopaminergic agonist (apomorphine) in the dog.
    Jauzac P; Blasco A; Vigoni F; Valdiguie P; Bès A
    J Cereb Blood Flow Metab; 1982 Sep; 2(3):369-72. PubMed ID: 7096461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interference between central dopaminergic stimulation, and adrenal secretion in normoxic or hypobaric hypoxic rats.
    Saligaut C; Moore N; Chretien P; Daoust M; Richard O; Boismare F
    Stroke; 1982; 13(6):859-64. PubMed ID: 7147306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of peripheral and central administration of apomorphine and morphine on intragastric pressure in the dog.
    Blancquaert JP; Lefebvre RA; Willems JL
    Eur J Pharmacol; 1985 Jan; 107(2):133-40. PubMed ID: 3979424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic control of the cough reflex as demonstrated by the effects of apomorphine.
    Kamei J; Hukuhara T; Kasuya Y
    Eur J Pharmacol; 1987 Sep; 141(3):511-3. PubMed ID: 3666045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypotension and bradycardia by intravenous apomorphine in the anaesthetized cat: no evidence for a central mechanism.
    De Meyer JM; Buylaert WA; Bogaert MG
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):166-7. PubMed ID: 7092413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.